# Vestal Point Capital, LP 13F holdings Q2 2026: $4.3 billion

Vestal Point Capital, LP reported $4.3 billion in 13F securities across 68 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Biomarin Pharmaceutical Inc at $345 million, 8.1% of the reported value. Since Q1 2026 it opened 11 new positions and exited 33.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $4,279,457,817
- Positions: 68
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1974915
- Form 13F file number: 028-23784
- Business address: 632 Broadway Suite 602, New York, NY 10012
- SEC filing: [0001974915-26-000005](https://www.sec.gov/Archives/edgar/data/1974915/000197491526000005/0001974915-26-000005-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/vestal-point-capital-lp-325894)

## Top 25 holdings by value

The largest of 68 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Biomarin Pharmaceutical Inc](https://specstream.ai/data/institutional-holders/biomarin-pharmaceutical-inc-09061g101) | COM | 6,025,000 | $344.8 million | +2,450,000 |
| [Neurocrine Biosciences Inc](https://specstream.ai/data/institutional-holders/neurocrine-biosciences-inc-64125c109) | COM | 1,880,000 | $316.8 million | +630,000 |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 2,349,443 | $313.1 million | +849,443 |
| [United Therapeutics Corp Del](https://specstream.ai/data/institutional-holders/united-therapeutics-corp-del-91307c102) | COM | 435,000 | $235.7 million | +360,000 |
| [Enliven Therapeutics Inc](https://specstream.ai/data/institutional-holders/enliven-therapeutics-inc-29337e102) | COM | 4,000,000 | $203 million | +750,000 |
| [Nurix Therapeutics Inc](https://specstream.ai/data/institutional-holders/nurix-therapeutics-inc-67080m103) | COM | 8,050,000 | $195.3 million | +1,550,000 |
| [Bicara Therapeutics Inc](https://specstream.ai/data/institutional-holders/bicara-therapeutics-inc-055477103) | COM | 5,250,000 | $155.9 million | -175,000 |
| [Taysha Gene Therapies Inc](https://specstream.ai/data/institutional-holders/taysha-gene-therapies-inc-877619106) | COM SHS | 19,415,000 | $132.2 million | +1,415,000 |
| [Arrowhead Pharmaceuticals in](https://specstream.ai/data/institutional-holders/arrowhead-pharmaceuticals-in-04280a100) | COM | 1,575,000 | $128.4 million | -700,000 |
| [Abbott Laboratories](https://specstream.ai/data/institutional-holders/abbott-laboratories-002824100) | COM | 1,400,000 | $127 million | New |
| [Zimmer Biomet Holdings Inc](https://specstream.ai/data/institutional-holders/zimmer-biomet-holdings-inc-98956p102) | COM | 1,400,000 | $120.5 million | +1,210,000 |
| [Disc Medicine Inc](https://specstream.ai/data/institutional-holders/disc-medicine-inc-254604101) | COM | 1,550,000 | $113.4 million | +850,000 |
| [Monte Rosa Therapeutics Inc](https://specstream.ai/data/institutional-holders/monte-rosa-therapeutics-inc-61225m102) | COM | 4,600,000 | $111.3 million | +996,535 |
| [Insulet Corp](https://specstream.ai/data/institutional-holders/insulet-corp-45784p101) | COM | 670,000 | $102 million | +619,399 |
| [Ascendis Pharma A/S](https://specstream.ai/data/institutional-holders/ascendis-pharma-a-s-k08588103) | ORD SHS | 375,000 | $100 million | New |
| [Astrazeneca PLC](https://specstream.ai/data/institutional-holders/astrazeneca-plc-g0593m107) | ORD | 450,000 | $85.3 million | +350,000 |
| [Sanofi SA](https://specstream.ai/data/institutional-holders/sanofi-sa-80105n105) | SPONSORED ADR | 2,000,000 | $85.3 million | +600,000 |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 450,000 | $84.3 million | -1,925,000 |
| [Biocryst Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/biocryst-pharmaceuticals-inc-09058v103) | COM | 8,300,000 | $83 million | +1,275,000 |
| [Dyne Therapeutics Inc](https://specstream.ai/data/institutional-holders/dyne-therapeutics-inc-26818m108) | COM | 3,375,000 | $75 million | -625,000 |
| [Nektar Therapeutics](https://specstream.ai/data/institutional-holders/nektar-therapeutics-640268306) | COM NEW | 1,000,000 | $69.8 million | +715,000 |
| [Globus Med Inc](https://specstream.ai/data/institutional-holders/globus-med-inc-379577208) | CL A | 850,000 | $67.2 million | +239,480 |
| [Tarsus Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/tarsus-pharmaceuticals-inc-87650l103) | COM | 1,050,000 | $66.1 million | +850,000 |
| [Immatics N.V](https://specstream.ai/data/institutional-holders/immatics-n-v-n44445109) | SHS | 6,175,000 | $62.6 million | No change |
| [Trevi Therapeutics Inc](https://specstream.ai/data/institutional-holders/trevi-therapeutics-inc-89532m101) | COM | 3,100,000 | $57.8 million | +933,496 |

## New positions in Q2 2026

11 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Abbott Laboratories](https://specstream.ai/data/institutional-holders/abbott-laboratories-002824100) | COM | 1,400,000 | $127 million |
| [Ascendis Pharma A/S](https://specstream.ai/data/institutional-holders/ascendis-pharma-a-s-k08588103) | ORD SHS | 375,000 | $100 million |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 250,000 | $26.7 million |
| [First Tracks Biotherapeutics](https://specstream.ai/data/institutional-holders/first-tracks-biotherapeutics-337185102) | ORD SHS | 1,013,000 | $20.4 million |
| [Avalo Therapeutics Inc](https://specstream.ai/data/institutional-holders/avalo-therapeutics-inc-05338f306) | COM NEW | 775,000 | $14.3 million |
| [Evommune Inc](https://specstream.ai/data/institutional-holders/evommune-inc-30054y107) | COM SHS | 1,000,000 | $13.3 million |
| [Kailera Therapeutics Inc](https://specstream.ai/data/institutional-holders/kailera-therapeutics-inc-482931102) | COMMON STOCK | 575,000 | $12.7 million |
| [Ibio Inc](https://specstream.ai/data/institutional-holders/ibio-inc-451033708) | COM NEW | 2,600,000 | $4.6 million |
| [Sagimet Biosciences Inc](https://specstream.ai/data/institutional-holders/sagimet-biosciences-inc-786700104) | COM SER A | 535,452 | $4.1 million |
| [Engene Therapeutics Inc](https://specstream.ai/data/institutional-holders/engene-therapeutics-inc-29286x101) | COM | 1,667,430 | $2.9 million |
| [Rezolute Inc](https://specstream.ai/data/institutional-holders/rezolute-inc-76200l309) | COM NEW | 382,999 | $2 million |

## Positions exited in Q2 2026

33 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then. The 25 largest are shown.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Apogee Therapeutics Inc](https://specstream.ai/data/institutional-holders/apogee-therapeutics-inc-03770n101) | COM | 1,100,000 | $92.6 million |
| Ascendis Pharma A/S | SPONSORED ADR | 375,000 | $85.8 million |
| [Scholar Rock HLDG Corp](https://specstream.ai/data/institutional-holders/scholar-rock-hldg-corp-80706p103) | COM | 1,324,422 | $65.1 million |
| [Vera Therapeutics Inc](https://specstream.ai/data/institutional-holders/vera-therapeutics-inc-92337r101) | CL A | 1,368,159 | $55 million |
| Terns Pharmaceuticals Inc | COM | 1,000,000 | $52.7 million |
| [Boston Scientific Corp](https://specstream.ai/data/institutional-holders/boston-scientific-corp-101137107) | COM | 800,000 | $50.2 million |
| [Nuvalent Inc](https://specstream.ai/data/institutional-holders/nuvalent-inc-670703107) | COM | 481,715 | $49.4 million |
| [Cogent Biosciences Inc](https://specstream.ai/data/institutional-holders/cogent-biosciences-inc-19240q201) | COM | 1,230,888 | $47.4 million |
| [Celldex Therapeutics Inc New](https://specstream.ai/data/institutional-holders/celldex-therapeutics-inc-new-15117b202) | COM NEW | 1,224,165 | $38.8 million |
| Kalvista Pharmaceuticals Inc | COM | 1,850,000 | $37.2 million |
| [Protagonist Therapeutics Inc](https://specstream.ai/data/institutional-holders/protagonist-therapeutics-inc-74366e102) | COM | 326,159 | $34.4 million |
| [Denali Therapeutics Inc](https://specstream.ai/data/institutional-holders/denali-therapeutics-inc-24823r105) | COM | 1,773,326 | $34 million |
| [Waters Corp](https://specstream.ai/data/institutional-holders/waters-corp-941848103) | COM | 100,000 | $29.8 million |
| [Inspire Med Sys Inc](https://specstream.ai/data/institutional-holders/inspire-med-sys-inc-457730109) | COM | 539,269 | $27.8 million |
| Soleno Therapeutics Inc | COM | 730,000 | $24.4 million |
| [Cytokinetics Inc](https://specstream.ai/data/institutional-holders/cytokinetics-inc-23282w605) | COM NEW | 300,000 | $19.8 million |
| [West Pharmaceutical SVSC Inc](https://specstream.ai/data/institutional-holders/west-pharmaceutical-svsc-inc-955306105) | COM | 75,000 | $18.8 million |
| [Genedx Holdings Corp](https://specstream.ai/data/institutional-holders/genedx-holdings-corp-81663l200) | COM CL A | 250,000 | $16.1 million |
| [Agios Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/agios-pharmaceuticals-inc-00847x104) | COM | 450,000 | $15.2 million |
| Engene Holdings Inc | COM | 2,165,000 | $14.7 million |
| [Arvinas Inc](https://specstream.ai/data/institutional-holders/arvinas-inc-04335a105) | COM | 905,465 | $9.6 million |
| [Maplight Therapeutics Inc](https://specstream.ai/data/institutional-holders/maplight-therapeutics-inc-56565p103) | COM | 420,000 | $8.5 million |
| [Fulcrum Therapeutics Inc](https://specstream.ai/data/institutional-holders/fulcrum-therapeutics-inc-359616109) | COM | 1,100,000 | $8.4 million |
| [Candel Therapeutics Inc](https://specstream.ai/data/institutional-holders/candel-therapeutics-inc-137404109) | COM | 1,125,000 | $5.5 million |
| [Veracyte Inc](https://specstream.ai/data/institutional-holders/veracyte-inc-92337f107) | COM | 130,687 | $4.2 million |

## Also on SpecStream

- [Vestal Point Capital, LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1974915/000197491526000005/0001974915-26-000005-index.htm)
- [Vestal Point Capital, LP investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/vestal-point-capital-lp-325894)
- [Largest 13F filers in New York](https://specstream.ai/data/institutional-holdings/state/new-york)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New York, New York

- [Private investigators in New York, New York](https://specstream.ai/data/businesses/private-investigators/new-york-new-york-united-states)
- [Employment law firms in New York, New York](https://specstream.ai/data/businesses/employment-law-firms/new-york-new-york-united-states)
- [Thai restaurants in New York, New York](https://specstream.ai/data/businesses/thai-restaurants/new-york-new-york-united-states)
- [Jamaican restaurants in New York, New York](https://specstream.ai/data/businesses/jamaican-restaurants/new-york-new-york-united-states)
- [Breweries in New York, New York](https://specstream.ai/data/businesses/breweries/new-york-new-york-united-states)
- [Periodontics practices in New York, New York](https://specstream.ai/data/businesses/periodontics-practices/new-york-new-york-united-states)
